Validation of the screening tool ApneaLink® in comparison to polysomnography for the diagnosis of sleep-disordered breathing in children and adolescents

Publication date: Available online 24 June 2017
Source:Sleep Medicine
Author(s): Florian Stehling, Judith Keull, Margarete Olivier, Jörg Große-Onnebrink, Uwe Mellies, Boris A. Stuck
ObjectiveWhile out-of-center testing was introduced as an alternative for the diagnosis of obstructive sleep apnea in adults, polysomnography (PSG) is still considered mandatory in the diagnosis of sleep-disordered breathing (SDB) in children. The purpose of this study was to validate the outpatient screening device ApneaLink® in comparison to PSG in children and adolescents for the diagnosis of SDB.MethodsSixty consecutive children and adolescents (10.4±6.2, 0–22 years) with suspected SDB admitted to the sleep laboratory underwent simultaneous recording with full PSG and the screening device ApneaLink® based on flow measurement and oxygen saturation.ResultsThe mean apnea–hypopnea index (AHI) was 11.8±19.7 in PSG and 10.3±12.0 in ApneaLink®. When the AHI threshold was set to 5/h to diagnose SDB, the overall sensitivity for ApneaLink® was 79% and the specificity was 63%. After reducing the AHI threshold to 1/h, the sensitivity and specificity were 94% and 29%. In children older than 10 years, the performance of ApneaLink® improved (AHI 5/h: sensitivity 80%, specificity 64%; AHI 1/h: sensitivity 100%, specificity 50%).ConclusionThese results show that the outpatient screening device ApneaLink® reliably identifies SDB in preselected children older than 10 years. In contrast, it may not be used for the exclusion of SDB.



from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2sDNHyS
via IFTTT